Patents by Inventor Seiji Kaku

Seiji Kaku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6057324
    Abstract: A substituted-amidinobenzene derivative of the following general formula (I) or a salt thereof, and a pharmaceutical composition comprising said derivative or a salt thereof and a pharmaceutically acceptable carrier. ##STR1## (the symbols in the above formula have the following meanings: R.sup.1 : a group which can be converted into an amidino group in vivo;R.sup.2 and R.sup.3 : the same or different and each represents a carboxyl group or a group which can be converted into a carboxyl group in vivo;X.sup.1 and X.sup.2 : the same or different and each represents a lower alkylene group;m: 0, 1 or 2;n: 0 or 1, provided that n=1 when m=0.They have GPIIb/IIIa receptor antagonizing activity and are useful as medicines for ameliorating ischemic cardiac disorders, adminicula in cardiosurgery operations or in vascular surgery operations, medicines for ameliorating cerebrovascular disorders, And medicines for ameliorating peripheral artery disorders.
    Type: Grant
    Filed: October 20, 1998
    Date of Patent: May 2, 2000
    Assignees: Yamanouchi Pharmaceutical Co., Ltd, Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Yuzo Matsumoto, Seijiro Akamatsu, Masato Ichihara, Tomihisa Kawasaki, Seiji Kaku, Isao Yanagisawa
  • Patent number: 5869501
    Abstract: An amidinonaphthyl derivative represented by the following general formula (I) which has coagulation factor X inhibiting action and is useful as an anti-thrombus agent and the like, a salt thereof, an intermediate thereof and a pharmaceutical composition which comprises the amidinonaphthyl derivative. An amidinonaphthyl derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. ##STR1## (symbols in the formula have the following meanings; R.sup.1 : a hydrogen atom or a group represented by the formula --A--W--R.sup.4,A: a group represented by the formula ##STR2## a group represented by the formula ##STR3## or a group represented by the formula --SO.sub.2 --, X: an oxygen atom or a sulfur atom, W: a single bond or a group represented by the formula --NR.sup.5 --, R.sup.4 : a hydroxyl group, a lower alkoxy group, etc., R.sup.5 : a hydrogen atom, a carbamoyl group, a lower alkoxycarbonyl group, etc., R.sup.2 : a lower alkyl group, R.sup.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: February 9, 1999
    Assignee: Yamanouchi Pharmaceutical Co. Ltd
    Inventors: Fukushi Hirayama, Hiroyuki Koshio, Yuzo Matsumoto, Tomihisa Kawasaki, Seiji Kaku, Isao Yanagisawa
  • Patent number: 5773442
    Abstract: Disclosed are benzamidine derivatives of the following general formula (I), salts thereof, hydrates thereof or solvates thereof, and pharmaceutical compositions comprising the derivatives, salts thereof, hydrates thereof or solvates thereof along with pharmaceutically-acceptable carriers. ##STR1## The derivatives and their compositions have GPIIb/IIIa receptor antagonistic activity and are useful for the treatment and prophylaxis of vascular system disorders as medicines for ameliorating ischemic cardiac disorders, adminicula in cardiosurgery operations or in vascular surgery operations, medicines for ameliorating cerebrovascular disorders, and medicines for ameliorating peripheral artery disorders.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: June 30, 1998
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Seijiro Akamatsu, Yuzo Matsumoto, Masato Ichihara, Tomihisa Kawasaki, Seiji Kaku, Isao Yanagisawa